SOP-016 / SOP v2.0
External testing, data and change control
Analytical partners, digital records and quality-system changes.
Procedure
- Agree in writing with the external laboratory on matrix, analyte, range, method, criteria, turnaround and deviation reporting.
- Check technical competence and, where relevant, accreditation scope. A general certificate does not establish suitability for every test.
- Maintain sample identity, conditions and receipt records. Link reports to the batch, method and raw data where needed.
- Restrict records by role. Keep change history, secure backups and restoration checks; do not upload patient details to the public website.
- Before material, method, source or equipment changes assess effects on strength, stability, exposure and previous batches. Define required comparisons.
- Approve changes only after testing, document updates and training. Monitor initial batches after implementation.
Edition-specific detail
The external-laboratory agreement defines matrix, analyte, concentration range, method validation/verification, critical LOQ, sample transport and raw data. Assess the relevant accredited scope, not merely a general certificate. Document source-edition or base-manufacturer changes in F-013/F-016 before release.
Stop criterion
Untraceable data or uncontrolled critical change: do not use for release.
Related forms
Sources and references
- NAPRA — Model Standards for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 4–9Risk, personnel, facilities and QA; its historical BUD table is not used for current USP defaults2026-09-12
- NAPRA — Guidance Document for Pharmacy Compounding of Non-sterile PreparationsMarch 2018, clarification January 2022Sections 5, 6 and 7; master/batch records, delivery, qualityQuality-system implementation; historical BUD table not substituted for 2022 USP revision2026-09-12
- PIC/S — Guide to Good Practices for the Preparation of Medicinal Products in Healthcare EstablishmentsPE 010-4, 1 March 2014Chapters 1–9; Annex 2 (nonsterile liquids, creams, ointments)Professional quality-system framework; not automatic national legal adoption or certification2026-09-12